Allergan Files Patent Infringement Lawsuit against Revance over Botox Patents
shot by IP News Shots / 5:32 pm on 06 October, 2021
Allergan, Inc. has filed a patent infringement lawsuit against Revance Therapeutics, Inc. over its botox patents. Allergan has asserted that Revance’s frown-line injection daxibotulinumtoxinA infringes several botox patents owned by the plaintiff. Revance was seeking the U.S. Food and Drug Administration’s (FDA) permission for the injection which was delayed due to the pandemic. Allergan is seeking the court’s verdict on rival’s infringement and damages.
Industry: Biotechnology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Fierce Pharma